When it comes to assessing your risk for heart disease and stroke, you’ve probably heard a lot about low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels. However, there’s another important factor that has been gaining attention in the medical community: lipoprotein(a), or Lp(a). Elevated levels of Lp(a) can significantly increase your risk for premature cardiovascular disease (CVD), especially when combined with other risk factors. Let’s dive into what Lp(a) is, how it impacts your heart health, and what you can do about it.

What is Lipoprotein(a) [Lp(a)]?

Lipoprotein(a), or Lp(a), is a type of lipoprotein similar to LDL but with an added protein called apolipoprotein(a). This unique structure makes Lp(a) particularly dangerous because it is associated with increased inflammation and atherosclerosis (the buildup of plaques in your arteries). While most people have low levels of Lp(a), about 20% of the population has significantly higher levels due to genetic factors.

Why is Lp(a) Important?

Lp(a) is an independent risk factor for cardiovascular disease (CVD). Normal Lp(a) levels are below 30 mg/dL, and levels above this threshold can greatly increase the risk of heart attack, stroke, and aortic stenosis (narrowing of the aortic valve). Elevated Lp(a) levels are particularly concerning for individuals with a family history of early CVD, diabetes, hypertension, stroke, or kidney disease. Certain ethnic groups, such as African Americans and South Asians, are also more likely to have higher Lp(a) levels.

How Does Lp(a) Affect Heart Health?

Lp(a) contributes to cardiovascular disease through several mechanisms:

  • Pro-inflammatory: Lp(a) enhances inflammation in blood vessels, leading to plaque formation.
  • Pro-thrombotic: Lp(a) carries oxidized phospholipids, which increase the blood’s tendency to clot.
  • Pro-oxidative: Lp(a) increases oxidative stress, causing damage to blood vessel walls.
  • Procalcific: Lp(a) can lead to calcification in the arterial wall and aortic valve, contributing to atherosclerosis and aortic stenosis.

These factors make Lp(a) more atherogenic (plaque-forming) than LDL, further increasing the risk of cardiovascular events.

How Are Lp(a) Levels Measured?

Lp(a) levels are determined through a simple blood test, but it is not typically included in standard cholesterol screenings. If you have a family history of heart disease or early-onset cardiovascular disease, it’s recommended to have your Lp(a) levels checked at least once in your lifetime. Since Lp(a) levels are largely stable throughout life, averaging two measurements can provide an accurate risk assessment.

Current Guidelines and Recommendations

Major health organizations like the American Heart Association (AHA) and the European Society of Cardiology (ESC) recommend Lp(a) screening for individuals with:

  • A family history of premature cardiovascular disease
  • Familial hypercholesterolemia
  • Intermediate or high risk for cardiovascular disease

Understanding your Lp(a) levels can help you and your healthcare provider develop a more comprehensive plan to manage your heart health.

Treatment and Management Options

Currently, there is no specific medication approved solely to lower Lp(a) levels. However, several strategies can help manage the overall cardiovascular risk:

Pharmacological Interventions:

  • Niacin (Vitamin B3): Can lower Lp(a) levels by about 20-30%, though its use is limited due to side effects.
  • PCSK9 Inhibitors: Medications like alirocumab and evolocumab can reduce Lp(a) levels by approximately 25-30%.
  • Apheresis: A procedure that filters Lp(a) from the blood, typically used in severe cases with extremely high Lp(a) levels. It can reduce Lp(a) levels by up to 70%.
  • Antisense Oligonucleotides: These are novel therapies in development that specifically target LPA mRNA, resulting in significant reductions in Lp(a) levels (up to 80%).

Lifestyle Modifications:

  • Diet and Exercise: While lifestyle changes have a limited effect on Lp(a) levels, maintaining a heart-healthy lifestyle is crucial. Diets rich in omega-3 and other unsaturated fats, such as the Mediterranean or DASH diets, may be beneficial.
  • Smoking Cessation: Quitting smoking is essential to reduce overall cardiovascular risk.

Ongoing Research and Clinical Trials

Exciting research and clinical trials are underway to better understand Lp(a) and develop effective treatments. For example, the Lipoprotein(a) HORIZON Trial is investigating the efficacy of pelacarsen in reducing cardiovascular events in patients with elevated Lp(a) levels. Additionally, studies are exploring the benefits of lipoprotein apheresis and new genetic studies are further elucidating the role of Lp(a) in cardiovascular disease.

Conclusion

Lp(a) is an important but often overlooked factor in cardiovascular health. By understanding your Lp(a) levels and working with your healthcare provider, you can better manage your risk of heart disease and stroke. Stay informed, get tested if you have risk factors, and adopt a heart-healthy lifestyle to protect your cardiovascular health. As research continues, we hope to see new therapies that specifically target Lp(a), offering more options for those at risk.

Stay proactive about your heart health, and don’t hesitate to ask your doctor about Lp(a) during your next visit. Knowledge is power when it comes to preventing cardiovascular disease!